Inari Medical, Inc. (NASDAQ:NARI) Shares Sold by Cresset Asset Management LLC

Cresset Asset Management LLC decreased its holdings in Inari Medical, Inc. (NASDAQ:NARI) by 57.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 11,327 shares of the company’s stock after selling 15,272 shares during the quarter. Cresset Asset Management LLC’s holdings in Inari Medical were worth $578,000 as of its most recent filing with the SEC.

Other institutional investors have also modified their holdings of the company. Smartleaf Asset Management LLC lifted its stake in shares of Inari Medical by 128.1% in the fourth quarter. Smartleaf Asset Management LLC now owns 634 shares of the company’s stock worth $33,000 after acquiring an additional 356 shares in the last quarter. R Squared Ltd acquired a new stake in Inari Medical during the fourth quarter valued at approximately $45,000. Quarry LP acquired a new stake in Inari Medical during the fourth quarter valued at approximately $57,000. Quadrant Capital Group LLC raised its stake in Inari Medical by 12.3% during the fourth quarter. Quadrant Capital Group LLC now owns 1,301 shares of the company’s stock valued at $66,000 after buying an additional 143 shares in the last quarter. Finally, KBC Group NV raised its stake in Inari Medical by 31.5% during the fourth quarter. KBC Group NV now owns 2,333 shares of the company’s stock valued at $119,000 after buying an additional 559 shares in the last quarter. Institutional investors and hedge funds own 90.98% of the company’s stock.

Inari Medical Price Performance

Shares of NASDAQ NARI opened at $79.97 on Wednesday. The stock’s 50 day moving average price is $79.97 and its two-hundred day moving average price is $70.01. Inari Medical, Inc. has a 52-week low of $39.76 and a 52-week high of $79.99. The stock has a market capitalization of $4.68 billion, a P/E ratio of -59.24 and a beta of 1.02.

Inari Medical Company Profile

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.